发明名称 Imidazolyl derivatives
摘要 The present invention is directed to imidazolyl derivatives of the formula:where the substituents are defined in the specification, or a pharmaceutically acceptable salt thereof. The derivatives bind selectively to the somatostatin subtype receptors and elicit either an agonist or antagonist effect from the somatostatin subtype receptors. The derivatives are useful for treating a variety of diseases including acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis, hyperinsulinism, gastrinoma, Zollinger-Ellison Syndrome, diarrhea, AIDS related diarrhea, chemotherapy related diarrhea, scleroderma, Irritable Bowel Syndrome, pancreatitis, small bowel obstruction, gastroesophageal reflux, duodenogastric reflux, Cushing's Syndrome, gonadotropinoma, hyperparathyroidism, Graves' Disease, diabetic neuropathy, Paget's disease, polycystic ovary disease, cancer, cancer cachexia, hypotension, postprandial hypotension, panic attacks, GH secreting adenomas or TSH secreting adenomas.
申请公布号 AU4425799(A) 申请公布日期 1999.12.30
申请号 AU19990044257 申请日期 1999.06.08
申请人 SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQU 发明人 CHRISTOPHE ALAIN THURIEAU;LYDIE FRANCINE POITOUT;MARIE-ODILE GALCERA;THOMAS D. GORDON;BARRY MORGAN;CHRISTOPHE PHILIPPE MOINET
分类号 C07D233/60;A61K31/40;A61K31/415;A61K31/4174;A61K31/4178;A61K31/4184;A61K31/4188;A61K31/4985;A61P1/04;A61P1/06;A61P1/12;A61P1/18;A61P3/06;A61P3/10;A61P5/02;A61P5/06;A61P5/18;A61P5/48;A61P7/04;A61P9/00;A61P9/02;A61P9/10;A61P13/12;A61P15/00;A61P17/00;A61P25/00;A61P25/22;A61P27/02;A61P29/00;A61P31/04;A61P35/00;A61P37/06;A61P43/00;C07D209/56;C07D211/30;C07D233/00;C07D233/54;C07D233/64;C07D235/16;C07D401/00;C07D401/06;C07D401/14;C07D403/06;C07D403/14;C07D405/06;C07D405/14;C07D409/14;C07D413/10;C07D471/04;C07D471/10;C07D487/04;C07D491/14 主分类号 C07D233/60
代理机构 代理人
主权项
地址